Association of HLA Class II Alleles and Haplotypes with Type 1 Diabetes in Tunisian Arabs.


Journal

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
ISSN: 1439-3646
Titre abrégé: Exp Clin Endocrinol Diabetes
Pays: Germany
ID NLM: 9505926

Informations de publication

Date de publication:
Oct 2019
Historique:
pubmed: 15 11 2018
medline: 27 3 2020
entrez: 15 11 2018
Statut: ppublish

Résumé

The molecular association of HLA class II with type 1 diabetes (T1DM) was investigated in Tunisian Arabs using 3 kinds of analyses. The first was a case-control association study, using Relative Predispositional Effects method, involved 137 T1DM cases and 258 control subjects. The second was family-based association-linkage study, using Transmission Disequilibrium Test, and covering 50 Tunisian families comprising 73 T1DM patients and 100 parents. The third was a wide correlation study between 4 DRB1 alleles (DRB1*03, *04, *11, *15) and T1DM in 52 countries, using Spearman's Rho. Results from Case-control and family-based association studies showed that DRB1*03 and DRB1*04 alleles predispose to T1DM in Tunisian Arabs. Conversely, only DRB1*11 was protective for T1DM. DRB1*04-DQB1*03 haplotype was consistently associated positively with T1DM; DRB1*03/DRB1*04 genotype had the highest risk of T1DM development. Compared to DRB1*03, HLA-DRB1*04 was associated with higher T1DM incidence. Thus, the contribution of HLA class II to T1DM genetic susceptibility must be evaluated with regards to specific HLA alleles, genotypes, and haplotypes, and also ethnic and racial background.

Identifiants

pubmed: 30428494
doi: 10.1055/a-0754-5586
doi:

Substances chimiques

HLA-DRB1 Chains 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

653-662

Informations de copyright

© Georg Thieme Verlag KG Stuttgart · New York.

Déclaration de conflit d'intérêts

The authors declare that they have no conflict of interest.

Auteurs

Abdelhafidh Hajjej (A)

Department of Immunogenetics, National Blood Transfusion Center, Tunis, Tunisia.

Wassim Y Almawi (WY)

School of Pharmacy, Lebanese American University, Byblos, Lebanon.
Department of Biological Sciences, Faculty of Sciences, El-Manar University, Tunis, Tunisia.

Mouna Stayoussef (M)

Department of Biological Sciences, Faculty of Sciences, El-Manar University, Tunis, Tunisia.

Lasmar Hattab (L)

Department of Medical Analysis, Regional Hospital of Gabes (Ghannouch), Gabes, Tunisia.

Slama Hmida (S)

Department of Immunogenetics, National Blood Transfusion Center, Tunis, Tunisia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH